Global plastic production in 1950, when large-scale industrial manufacture of polymer resins and synthetic fibres had just begun, was approximately 2 million tonnes. Global plastic production in 2019 was approximately 460 million tonnes. The ratio is about 230 to 1. In seven decades, plastic has gone from being a specialty material made in modest quantities to one of the most ubiquitous synthetic substances on Earth, manufactured at a scale that exceeds nearly every other industrial material except steel and cement. The rate is still accelerating. According to a 2022 OECD report on global plastics, total annual production is projected to reach 1,231 million tonnes by 2060 in the absence of significant new policies.
The materials are useful, lightweight, durable, and cheap to produce, which is why their consumption has expanded so rapidly. They are also extraordinarily persistent in the natural environment, which is why most of the plastic ever produced still exists in some form somewhere on Earth. According to the 2017 paper by Roland Geyer and colleagues at UC Santa Barbara, published in Science Advances, the cumulative total of all plastic produced from 1950 through 2015 was approximately 8.3 billion tonnes, of which 6.3 billion tonnes had already become waste. Half of all plastics ever produced in human history were made in the 13 years between 2004 and 2015. The pace has not slowed since.
Where it actually goes
The popular framing of plastic as a recyclable material does not match the actual numbers. According to the OECD’s Global Plastics Outlook, of all plastic waste generated worldwide in 2019, only 9 percent was successfully recycled. About 19 percent was incinerated, often in waste-to-energy facilities that capture some of the calorific value of the plastic by burning it. About 50 percent was sent to sanitary landfills. The remaining 22 percent — approximately 78 million tonnes per year — was disposed of in uncontrolled dumpsites, burned in open pits, or leaked directly into the environment. Of that mismanaged fraction, the OECD estimates that 22 million tonnes per year ends up in the environment as macroplastic or microplastic pollution, where most of it will persist for decades to centuries.
The 9 percent recycling figure has been roughly stable for two decades. A 2025 study published in the journal Communications Earth and Environment found that the global plastic recycling rate is essentially “stagnant” at around 9 percent despite repeated commitments by governments and industry to increase it. The reasons are economic rather than technical. Recycling most plastics is more expensive than producing new plastic from petroleum feedstocks, particularly with cheap natural gas and oil keeping virgin polymer prices low. Many types of plastic are mechanically difficult to recycle because they are blends of multiple polymer types, contain additives that compromise recycled material quality, or are contaminated with food residues, labels, or other materials. The phrase “designed to be recycled” appears on a great many plastic products. The actual fraction that gets recycled is, in most product categories, well under 10 percent.
What ends up in the human body
Plastic does not biodegrade in any meaningful timescale, but it does fragment. Sunlight, mechanical stress, and weathering break larger plastic items into progressively smaller pieces. Particles below 5 millimetres in diameter are classified as microplastics. Particles below 1 micrometre are classified as nanoplastics. Both are now ubiquitous in the global environment, in soil, in fresh water, in marine sediments, in the atmosphere, and in food.
The implications for human health are an active area of research, and the findings of the past five years have been striking. The first documented detection of microplastics in human blood was reported in 2022 by a team at Vrije Universiteit Amsterdam led by Heather Leslie, in a study published in Environment International; the team found measurable microplastic concentrations in 77 percent of the volunteer blood samples tested. The first documented detection of microplastics in human placental tissue came earlier, in a 2021 study by Antonio Ragusa and colleagues at the Fatebenefratelli Hospital in Rome, also in Environment International, which gave the world the term “Plasticenta.” Subsequent work has detected microplastics in human heart tissue, lung tissue, liver, kidney, testicles, breast milk, semen, and meconium (newborn’s first stool).
The most striking recent finding came in early 2025. According to a paper in Nature Medicine by Matthew Campen and colleagues at the University of New Mexico, microplastics and nanoplastics are now detectable in human brain tissue, with concentrations that have risen significantly between 2016 and 2024. Brain samples collected in 2024 contained about 50 percent more microplastics by mass than samples collected eight years earlier from comparable populations. The plastic was concentrated in the frontal cortex and consisted primarily of polyethylene shards at the nanoscale. The Campen study also found significantly higher brain microplastic levels in decedents who had dementia at the time of death, though the directionality of any causal relationship is not yet established.
What the health implications are
The health consequences of human microplastic exposure are still being characterised, and the science remains in motion. According to Stanford Medicine’s 2025 review of the evidence, the first major direct-risk study in humans was published in the New England Journal of Medicine in March 2024. The team examined plaque samples taken from patients undergoing surgery to remove arterial buildup. Patients whose plaque contained microplastics were found, over a 34-month follow-up period, to have a substantially higher risk of heart attack, stroke, and death than patients whose plaque did not. The mechanism is unclear, but the correlation was strong enough to be statistically significant and clinically relevant.
Most of the active research is focused on understanding what microplastics actually do to the tissues they accumulate in. Microplastic particles appear to enter cells, produce oxidative stress, alter gene expression, and in some experimental systems trigger inflammation. The smaller particles, nanoplastics, can cross biological barriers — including the blood-brain barrier and the placental barrier — that microplastics cannot. The additives and contaminants carried on plastic particles, including bisphenols, phthalates, and various flame retardants, have their own established health effects, including endocrine disruption. The plastic itself may be relatively inert, but the chemical hitchhikers it carries are not.
The honest summary of the situation is that the world is conducting an unintentional uncontrolled experiment in human exposure to a class of synthetic materials whose long-term health effects are not yet understood. The exposure is ubiquitous; recent studies have detected microplastics in essentially every human population sampled. The cumulative dose is rising. The 9 percent recycling rate has not increased in two decades, the production rate continues to grow, and the persistence of the materials in the environment guarantees that the exposure will continue regardless of any reduction in future production. The plastic that exists already, plus the plastic still being made, is now part of the planet’s permanent material inventory — and increasingly, part of the human body’s.
